IP Library Assignment 024937/0796
Patent Assignment
Reel/Frame 024937/0796

Assignment of Assignor's Interest

Recorded: 2010-09-03 Pages: 5
Assignors
DITULLIO, PAUL
Executed: 1995-03-09
MEADE, HARRY
Executed: 1995-03-08
COLE, EDWARD S.
Executed: 1995-03-08
Assignee
GENZYME TRANSGENIC CORPORATION
ONE MOUNTAIN ROAD, FRAMINGHAM, MASSACHUSETTS, 01701
Covered Property (1)
Transgenically Produced Antithrombin Iii
Patent: 7,928,064 →
Application: 11/284,585 →
Publication: US 2008/0176786
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement Dec 22, 2008
From: GTC BIOTHERAPEUTICS, INC.
To: LFB BIOTECHNOLOGIES S.A.S.U.
Reel/Frame 022019/0205 →
Security Agreement Jan 16, 2009
From: GTC BIOTHERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 022119/0854 →
Change of Name Sep 3, 2010
From: GENZYME TRANSGENICS CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 024937/0709 →
Change of Name Jul 18, 2013
From: GTC BIOTHERAPEUTICS, INC.
To: REVO BIOLOGICS, INC.
Reel/Frame 030831/0075 →
Release of Security Interest Mar 11, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032424/0230 →
Release of Security Interest Mar 14, 2014
From: LFB BIOTECHNOLOGIES S.A.S.U.
To: GTC BIOTHERAPEUTICS, INC.
Reel/Frame 032448/0045 →